Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
81.15
-0.55 (-0.67%)
May 28, 2026, 2:32 PM EDT - Market open
Kymera Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $106 | Buy | Maintains | $106 | +30.62% | May 20, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $134 | Buy | Maintains | $134 | +65.13% | May 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 1, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $125 | Buy | Reiterates | $125 | +54.04% | May 1, 2026 |
| Citi | Citi | Buy Maintains $120 | Buy | Maintains | $120 | +47.87% | May 1, 2026 |
| Barclays | Barclays | Buy Maintains $133 | Buy | Maintains | $133 | +63.89% | May 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $123 → $119 | Buy | Reiterates | $123 → $119 | +46.64% | Apr 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.